Analysts think ARWR stock price could increase by 247%
Apr 04, 2025, 11:25 AM
19.44%
What does ARWR do
Arrowhead Pharmaceuticals, based in Pasadena, California, develops RNA-based therapies targeting intractable diseases, employing 525 staff and featuring 14 clinical-stage investigational medicines across various therapeutic areas. Their TRiMTM platform enables tissue-specific delivery through RNA interference mechanisms.
15 analysts think ARWR stock price will increase by 246.77%. The current median analyst target is $41.82 compared to a current stock price of $12.06. The lowest analysts target is $21.21 and the highest analyst target is $84.00.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.